HESI Pharmacology Practice Exam Questions And Answers Well Illustrated.

HESI Pharmacology Practice Exam Questions And Answers Well Illustrated. Following nthe nadministration nof nsublingual nnitroglycerin nto na nclient nexperiencing nan nacute nanginal nattack, nwhich nassessment nfinding nindicates nto nthe nnurse nthat nthe ndesired neffect nhas nbeen nachieved? n A. nClient nstates nchest npain nis nrelieved B. nClient's npulse ndecreases nfrom n120 nto n90 C. nClient's nsystolic nblood npressure ndecreases nfrom n180 nto n90 D. nClients nSaO2 nlevel nincreases nfrom n92% nto n96% n- n n n ncorrect nanswer.A. nnitroglycerin nreduces nmycocardial noxygen nconsumption nwhich ndecreases nischemia nand nreduces nchest npain A nclient nwith nhyperlipidemia nrecieves na nprescription nfor nniacin n(niaspan). nwhich nclient nteaching nis nmost nimportant nfor nthe nnurse nto nprovide a. nexpected nduration nof nflushing b. nsymptoms nof nhyperglycemia c. ndiets nthat nminimize ngi nirritation d. ncomfort nmeasure nfor npruritis n- n n n ncorrect nanswer.A. nflushing nof nthe nface nand nneck, nlasting nup nto nan nhour, nis na nfrequent nreason nfor ndiscontinuing nniacin. ninclusion nof nthis neffect nin nclietn nteaching nmay npromote ncompliance nin ntaking nthe nmed. When nassessing nan nadolescent nwho nrecently noverdosed non nacetaminophen n(tylonel), nit nis nmost nimportant nfor nthe nnurse nto nassess nfor npain nin nwhich narea nof nthe nbody a. nflank b. nabdomen c. nchest d. nhead n- n n n ncorrect nanswer.B. nacetaminophen ntoxicisty nan nresult nin nliver ndamage; ntherefore, nit nis nespecially nimportant nfor nthe nnurse nto nassess nfor npain nin nthe nright nupper nquadrant nof nthe nabdomen n(which nmight nindicated nliver ndamage) A nclient nis nadmitted nto nthe ncoronary ncare nunit nwith na nmedical ndiagnosis nof nacute nmyocardial ninfarction. nwhich nmedication nprescription ndecreases nboth npreload nand nafterload a. nnitroglycerin b. npropranolol c. npropranolol d. ncaptopril n- n n n ncorrect nanswer.A. nnitroglycerin nis na nnitrate nthat ncauses nperipheral nvasodilation nand ndecreases ncontractility, nthereby ndecreasing nboth npreload nand nafterload A nclient nis nbeing ntreated nfor nhyperthyroidism nwith npropylthiouracil n(PTU). nThe nnurse nknows nthat nthe naction nof nthis ndrug nis nto n A. ndecrease nthe namount nof nthe nthyroid-stimulating nhormone ncirculating nin nthe nblood B. nincrease nthe namount nof nthyroid-stimulating nhormone ncirculating nin nthe nblood C. nincrease nthe namount nof nT4 nand ndecrease nthe namount nof nT3 nproduced nby nthe nthyroid D. ninhibit nsynthesis nof nT3 nand nT4 nby nthe nthyroid ngland n- n n n ncorrect nanswer.D. nPTU nis nan nadjunct ntherapy nused nto ncontrol nhyperthyroidism nby ninhibiting nproduction nof nthyroid nhormones. nIt nis noften nprescribed nin nprep nfor nthyroidectomy nor nradioactive niodine ntherapy Which nchange nin ndata nindicates nto nthe nnurse nthe ndesired neffect nof nthe nangiotensin nII nreceptor nantagonist nhas nbeen nachieved A. nDependent nedema nreduced nform n+3 nto n+1 B. nSerum nHDL nincreased nfrom n35 nto n55mg/dl C. nPUlse nrate nreduced nfrom n150 nto n90 nbeats/min D. nBlood npressure nreducedf nrom n160/90 nto n130.80 n- n n n ncorrect nanswer.D. nangiotensin nII nreceptor nantagonist n(blocker), nprescribed nfrom ntreatment nof nHTN. nThe ndesired neffect nis na ndecrease nin nblood npressure. Which ninstructions nshould nthe nnurse ngive nto na nfemale nclient nwho njust nrecieved na nprescription nfor noral nmetronidazole n(flagyl) nfor ntreatment nof ntrichomonas nvaginalis n(select nall nthat napply) A. nincrease nfluid nintake, nespecially ncranberry njuice B. nDo nnot nabruptly ndiscontinue nthe nmedication; ntaper nuse C. nCheck nblood npressure ndaily nto ndetect nhypertension D. nAvoid ndrinking nalcohol nwhile ntaking nthis nmedication E. nUse ncondoms nuntil ntreatment nis ncompleted F. nEnsure nthat nall nsexual npartners nare ntreated nat nthe nsame ntime n- n n n ncorrect nanswer.ADEF The nnurse nis ntranscribing na nnew nprescription nfor nspironolactone n(aldactone) nfor na nclient nwho nreceives nan nangiotensin-converting nenzyme ninhibitor. nWhich naction nshould nthe nnurse nimplement A. nverify nboth nprescriptions nwith nthe nHCP B. nreport nthe nmed ninteractions nto nthe nnurse nmanager C. nhold nthe nACE ninhibitor nand ngive nthe nnew nprescription D. nTranscribe nand nsend nthe nprescription nto nthe npharmacy n- n n n ncorrect nanswer.A. nthe nconcomitant nuse nof nan nACE ninhibitor nand na npotassium-sparing ndiuretic nsucha ns nspironolactone, nshould nbe ngiven nwith ncaution nb/c nthe ntwo ndrugs nmay ninteract nto ncause nan nelevation nin nserum npotassium nlevels. A nclient nhas nmyxedema, nwhich nresults nfrom na ndeficiency nof nthyroid nhormone nsynthesis nin nadults. nThe nnurse nknows nthat nwhich nmedication nshould nbe ncontraindicated nfor nthis nclient? A. nliothyronine n(cytomel) nto nreplace niodine B. nFurosemide n(Lasix) nfor nrelief nof nfluid nretention C. nPentobarbital nsodium nfor nsleep D. nnitroglycerin nfor nangina npain n- n n n ncorrect nanswer.C. npersons nwith nmyxedema nare ndangerously nhypersensitive nto nnarcotics, nbarbiturates, nand nanesthetics. nThey ndo nnot ntolerate nliothyronine nand nusually nreceive niodine nreplacement ntherapy. nThese nclients nare nalso nsuceptable nto nheart nproblems nsuch nas nangina nfor nwhich nnitroglycerine nwould nbe nindicated nand nand ncongestive nheart nfailure nfor nwhich nfurosemide nwould nbe nindicated A nclient nhas na ncontinuous nIV ninfusion nof ndopamine nand nan nIV nof nnormal nsaline nat n50ml/hour. nThe nnurse nnoes nthat nthe nclient's nurinary noutput nhas nbeen n20ml/hour nfor nthe nlast ntwo nhours. nWhich nintervention nshould nthe nnurse ninitiate? A. nstop nthe ninfusion nof ndopamine B. nchange nthe nnormal nsaline nto na nkeep nopen nrate C. nreplace nthe nurinary ncatheter D. nnotify nthe nhealthcare nprovider nof nthe nurinary noutput. n- n n n ncorrect nanswer.D. A nhealthcare nprovider nprescrives ncephalexin nmonhydrate n(Keflex) nfor na nclient nwith na npostoperative ninfection. nIt nis nmost nimportant nfor nthe nnurse nto nassess nfor nwhat nadditional ndrug nallergy nbefore nadministering nthis nprescription? A. nPenicillins B. nAminoglycosides C. nErythromycins D.Sulfonamides n- n n n ncorrect nanswer.A. nCross-allergies nexist nbetween npenicillins nand ncephalosporines, nsuch nas nkeflex. nso nchecking nfor npenicillin nallergy nis na nwise nprecaution Which nmedications nshould nthe nnurse ncaution nthe nclient nabout ntaking nwhile nreceiving nan nopioid nanalgesic? A. nAntacids. n B. nBenzodiasepines C. nAntihypertensives D. nOral nantidiabetics n- n n n ncorrect nanswer.B. nrespiratory ndepression nincreases nwith nthe nconcurrent nuse nof nopioid nanalgesics nand nother ncns ndepressant nagents, nsuch nas nalcohol, nbarbiturates, nand nbenzodiasepines Which nnursing ndiagnosis nis nimportant nto ninclude nin nthe nplan nof ncare nfor na nclient nrecieving nthe nangiotensin nII nreceptor nantagonist nirbesartan n(avapro)? A. nFluid nvolume ndeficit B.Risk nfor ninfection C. nRisk nfor ninjury D. nImpaired nsleep npatterns n- n n n ncorrect nanswer.C. nAvapro nis nan nantihypertensive nagent, nwhich nacts nby nblocking nvasoconstrictor neffects nat nvarious nreceptor nsites. nThis ncan ncause nhypotension nand ndizziness, nplacing nthe nclient nat nhigh nrisk nfor ninjury A npostoperative nclient nhas nbeen nrecieving na ncontinuous nIV ninfusion nof nmeperidine n(demerol) n35mg/hr nfor nfour ndays. nThe nclient nhas na nPRN nprescription nfor nDemorol n100mg nPO nQ3H. nThe nnurse nnotes nthat nthe nclient nhas nbecome nincreasingly nrestless, nirritable nand nconfused, nstating nthat nthere nare nbugs nall nover nthe nwalls. nWhat naction nshould nthe nnurse ntake nFIRST? A. nAdminister na nPRN ndose nof nthe nPO nmeperidine n(demorol) B. nAdminister nnaloxone n(narcan) nIV nper nPRN nprotocol C. nDecrease nthe nIV ninfusion nrate nof nthe ndemerol nper nprotocol D. nnotify nthe nhealthcare nprovider nof nthe nclients nconfusion nand nhallucinations n- n n n ncorrect nanswer.C. nThe nclient nis nexhibiting nsymptoms nof ndemerol ntoxicity, nwhich nis nconsistent nwith nthe nlarge ndose nof ndemerol nrecieved nover nfour ndays. nC. nis nthe nmost neffective naction nto nimmediately ndecrease nthe namount nof nserum ndemerol. The nclient nwith na ndysrhythmia nis nto nreceive nprocainamide n(pronestyl) nin n4 ndivided ndoses nover nthe nnext n24 nhours. nWhat ndosing nschedule nis nbest nfor nthe nnurse nto nimplement? n A. nq6h B. nQID C. nAC nand nbedtime D. nPC nand nbedtime n- n n n ncorrect nanswer.A. nq6h After nabdominal nsurgery, na nmale nclient nis nprescribed nlow nmolecular nweight nheparin. nduring nadministration nof nthe nmedication, nthe nclient nasks nthe nnurse nwhy nhe nis nreceiving nthis nmedication. nWhich nis nthe nbest nresponse nfor nthe nnurse nto nprovide. n A. nThis nmedication nis na nblood nthinner ngiven nto nprevent nblood nclot nformation B. nthis nmedication nenhances nantibiotics nto nprevent ninfection C. nThis nmedication ndissolves nany nglots nthat ndevelop nint nhe nlegs D. nThis nabdominal ninjection nassists nin nthe nhealing nof nthe nabdominal nwound n- n n n ncorrect nanswer.A Following nheparin ntreatment nfor na nPE, na nclient nis nbeing ndischarged nwith na nprescription nfor nwarfarin. nIn nconducting ndischarge nteaching, nthe nnurse nadvises nthe nclient nto nhave nwhich ndiagnostic ntest nmonitored nregularly? A. nPerfusion nscan B. nProthrombin ntime n(PT/INR) C. nActivated nPartial nthromboplastin n(APTT) D. nSerum nCoumadin nLevel n(SCL) n- n n n ncorrect nanswer.B. nWhen nused nfor na nclient nwith nPE, nthe ntherapeutic ngoal nfor nwafarin ntherapy nis na nPT n1/5 nto n2/5 ntimes ngreater nthan nthe ncontrol nor nan nINR nof n2-3. nA nperfusion nmight nbe npreformed nto nmonitor nlung nfunction nbut nnot nmonthly. nAPTT nis nmonitored nfor nHeparin. A nclient nwho nhas nbeen ntaking nlevodopa nPO nTID nto ncontrol nthe nsymptoms nof nParkinsons ndisease nhas na nnew nprescription nfor nsustained nrelease nlevodopa/carbidopa n(sinemet n25/100 nPO nBID. nThe nclient ntook nhis nlevodopa nat n0800. nWhich ninstruction nshould nthe nnurse ninclude nin nthe nteaching nplan nfor nthis nclient? A. ntake nthe nfirst ndose nof nsinemet ntoday, nas nsoon nas nyour nprescription nis nfilld B. nSince nyou nalready ntook nyour nlevodopa, nwait nuntil ntomorrow nto ntake nthe nsinemet C. nTake nboth ndrugs nfor nthe n1st nweek, nthen nswitch nto ntaking nonly nthe nsinemet. D. nYou ncan nbegin ntaking nthe nsinemet nthis nevening, nbut ndo nnot ntake nanymore nlevodopa n- n n n ncorrect nanswer.D While ntaking na nnursing nhistory, nthe nclient nstates, n"I nam nallergice nto npenicillin." nwhat nrelated nallergy nto nanother ntype nof nanti-infective nagent nshould nthe nnurse nask nthe nclient nabout nwhen ntaking nnursing nhistory. n A. naminoglycosides B. nCephalosporins C. nSulfonamides D. nTetracyclines n- n n n ncorrect nanswer.B. nCross nallergies nexist nbetween npenicillins nand ncephalosporins A nclient nasks nthe nnurse nif nglipizide n(Glucotrol) nis nan noral ninsulin. nWhich nresponse nshould nthe nnurse nprovide? A. nYes nit nis nan noral ninsulin nand nhas nthe nsame nactions nand nproperties nas nintermediate ninsulin B. nYes, nit nis nan noral ninsulin nand nis ndistributed, nmetabolized, nand nexcreted nin nthe nsame nmanner nas ninsulin C. nNo nit nis nnot nan noral ninsulin nand ncan nbe nused nonly nwhen nsome nbeta ncell nfunction nis npresent D. nNo, nit nis nnot nan noral ninsulin, nbut nit nis neffective nfor nthose nwho nare nresistant nto ninjectable ninsulins n- n n n ncorrect nanswer.C An nadult nclient nhas nprescriptions nfor nmorphine nsulfate n2.5 nmg nIV nq6h nand nketorlac n(toradol) n30mg nIV nq6h. nwhich naction nshould nthe nnurse nimplement? A. nadminister nboth nmedications naccording nto nthe nprescription B. nHold nthe nketorolac nto nprevent nan nantagonist neffect C. nHold nthe nmorphine nto nprevent nan nadditive ndrug ninteraction D. nContact nthe nhealthcare nprovider nto nclarify nthe nprescription n- n n n ncorrect nanswer.A. nMorphine nand nketorolac ncan nbe nadministered nconcurrently nand nmay nproduce nadditive nanalgesic neffect nresulting nin nability nto nreduce nthe ndose nof nmorphine, nas nseen nin nthis nprescription The nhealthcare nprovider nprescribes ndigitalis n(Digoxin) nfor na nclient ndiagnosed nwith ncongestive nheart nfailure. nWhich nintervention nshould nthe nnurse nimplement nprior nto nadminstering nthe ndigoxin? A. nObserve nresp nrate nand ndepth B. nassess nthe nserum npotassium nlevel C. nObtain nthe nclients nblood npressure D. nMonitor nthe nserum nglucose nlevel n- n n n ncorrect nanswer.B. nhypokalemia n(decreased nserum npotassium) nwill nprecipitate ndigitalis ntoxicity nin npersons nreceiving ndigoxin An nantacid n(maalox) nis nprescribed nfor na nclient nwith nPUD. nThe nnurse nknows nthat nthe npurpose nof nthis nmedication nis nto A. nDecrease nproduction nof ngastric nsecretions B. nproduce nan nadherent nbarrier nover nthe nulcer C. nMaintain na ngastric npH nof n3.5 nor nabove D. ndecrease ngastric nmotor nactivity n- n n n ncorrect nanswer.C. Which nclient nshould nthe nnurse nidentify nas nbeing nat nthe nhighest nrisk nfor ncomplications nduring nthe nuse nof nan nopioid nanalgesic? A. nan nolder nclient nwith ntype n2 ndiabetes B. nA nclient nwith nchronic nrheumatoid narthritis C. nA nclient nwith na nopen ncompound nfracture D. nA nyoung nadult nwith ninflammatory nbowel ndisease n- n n n ncorrect nanswer.D A nclient nis nbeing ntreated nfor nosteoporosis nwith nalendronate n(fosamax), nand nthe nnurse nhas ncompleted ndischarge nteaching nregarding nmedication nadministration. nWhich nmorning nschedule nwould nindicated nto nthe nnurse nthat nthe nclient nteaching nhas nbeen neffective? A. ntake nmedication, ngo nfor na30 nminutes nmorning nwalk, nthen neat nbreakfast B. ntake nmed, nrest nin nbed nfor n30 nmin., neat nbreakfast, ngo nfor nmorning nwalk C. ntake nmedication nwith nbreakfast, nthen ntake na n30 nminute nmorning nwalk D. ngo nfor na n30minute nmorning nwalk, neat nbreakfast, nthen ntake nthe nmed n- n n n ncorrect nanswer.A. A nclient nis nreceiving nclonidine n(catapres) n0.1mg/24hr nvia ntransdermal npatch. nWhich nassessment nfinding nindicates nthat nthe ndesired neffect nof nthe nmedication nhas nbeen nachieved? n A. nclient ndenies nrecent nepisodes nof nangina B. nChange nin nperipheral nedema nfrom n+3 nto n+1 C. nClient ndenies nrecent nnausea nor nvomiting D. nBlood npressure nhas nchanged nfrom n180/120 nto n140/70 n- n n n ncorrect nanswer.D. nCatapres nacts nas na ncentrally-acting nanalgesic nand nantihypertensive nagent. nD. nindicates na nreduction nin nhypertention A nfemale nclient nwith nRA ntakes nibuprofen n(motrin) n600mg nPO n4xday. nTo npreven nGI nbleeding, nmisoprostol n(cytotec) n100mcg nPO nis nprescribed. nWhich ninformation nis nmost nimportant nfor nthe nnurse nto ninclude nin nclient nteaching? A. nuse ncontraception nduring nintercourse B. nensure nthe ncytotec nis ntaken non nan nempty nstomach C. nencourage noral nfluid nintake nto nprevent nconstipation D. ntake ncytotec n30min nprior nto nmotrin n- n n n ncorrect nanswer.A. nCytotec, na nsynthetic nform nof nprostaglandin, nis nclassified nas npregnancy ncategory nX nand ncan nact nas nan nabortifacient, nso nthe nclient nshould nbe ninstructed nto nuse ncontraception nduring nintercourse nto nprevent nloss nof nearly npregnancy Which ndosing nschedule nshould nthe nnurse nteach nthe nclient nto nobserve nfor na ncontrolled-release noxycodone nprescription n- n n n ncorrect nanswer.Q12H The nnurse nis nreviewing nthe nuse nof nthe npatient-controlled nanalgesia n(PCA) npump nwith na nclient nin nthe nimmediate npostoperative nperiod. nThe nclient nwill nreceive nmorphine n1mg nIV/hour nbasal nrate nwith n1mg nIV nevery n15minutes nper nPCA nto ntoal n5mg nIV nmax nper nhour. nWHat nassessment nhas nthe nhighest npriority nbefore ninitating nthe nPCA npump A. nThe nexpiration ndate non nthe nmorphine nsyringe nin nthe npump B. nThe nrate nand ndepth nof nthe nclient's nrespirations C. nThe ntype nof nanesthesia nused nduring nthe nsurgical nprocedure D. nThe nclient's nsubjective nand nobjective nsigns nof npain n- n n n ncorrect nanswer.ANS: nB A nlife-threatening nside neffect nof nintravenous nadministration nof nmorphine nsulfate, nan nopiate nnarcotic, nis nrespiratory ndepression n(B). nThe nPCA npump nshould nbe nstopped nand nthe nhealthcare nprovider nnotified nif nthe nclient's nrespiratory nrate nfalls nbelow n12 nbreaths nper nminute, nand nthe nnurse nshould nanticipate nadjustments nin nthe nclient's ndosage nbefore nthe nPCA npump nis nrestarted. A nclient nreceiving nalbuterol n(Proventil) ntablets ncomplains nof nnausea nevery nevening nwith nher n9 np.m. ndose. nWhat naction nshould nthe nnurse ntake nto nalleviate nthis nside neffect? A) nChange nthe ntime nof nthe ndose. n B) nHold nthe n9 np.m. ndose. n C) nAdminister nthe ndose nwith na nsnack. n D) nAdminister nan nantiemetic nwith nthe ndose. n- n n n ncorrect nanswer.C. Administering noral ndoses nwith nfood n(C) nhelps nminimize nGI ndiscomfort. n(A) nwould nbe nappropriate nonly nif nchanging nthe ntime nof nthe ndose ncorresponds nto nmeal ntimes nwhile nat nthe nsame ntime nmaintaining nan nappropriate ntime ninterval nbetween ndoses. n(B) nwould ndisrupt nthe ndosing nschedule, nand ncould nresult nin na nnontherapeutic nserum nlevel nof nthe nmedication. n(D) nshould nnot nbe nattempted nbefore nother ninterventions, nsuch nas n(C), nhave nbeen nproven nineffective nin nrelieving nthe nnausea. In nevaluating nthe neffects nof nlactulose n(Cephulac), nwhich noutcome nshould nindicate nthat nthe ndrug nis nperforming nas nintended? A) nAn nincrease nin nurine noutput. n B) nTwo nor nthree nsoft nstools nper nday. n C) nWatery, ndiarrhea nstools. n D) nIncreased nserum nbilirubin. n- n n n ncorrect nanswer.B. Lactulose nis nadministered nto nreduce nblood nammonia nby nexcretion nof nammonia nthrough nthe nstool. nTwo nto nthree nstools na nday nindicate nthat nlactulose nis nperforming nas nintended n(B). n(A) nwould nbe nexpected nif nthe npatient nreceived na ndiuretic. n(C) nwould nindicate nan noverdose nof nlactulose nand nis nnot nexpected. nLactulose ndoes nnot naffect n(D). A nclient nis nadmitted nto nthe nhospital nfor ndiagnostic ntesting nfor npossible nmyasthenia ngravis. nThe nnurse nprepares nfor nintravenous nadministration nof nedrophonium nchloride n(Tensilon). nWhat nis nthe nexpected noutcome nfor nthis nclient nfollowing nadministration nof nthis npharmacologic nagent? A) nProgressive ndifficulty nwith nswallowing. n B) nDecreased nrespiratory neffort. n C) nImprovement nin ngeneralized nfatigue. n D) nDecreased nmuscle nweakness. n- n n n ncorrect nanswer.D. Administration nof nedrophonium nchloride n(Tensilon), na ncholinergic nagent, nwill ntemporarily nreduce nmuscle nweakness n(D), nthe nmost ncommon ncomplaint nof nnewly-diagnosed nclients nwith nmyasthenia ngravis. nThis nmedication nis nused nto ndiagnose nmyasthenia ngravis ndue nto nits nshort nduration nof naction. nThis ndrug nwould ntemporarily nreverse n(A nand nB), nnot nincrease nthese nsymptoms. n(C) nis nnot na ntypical ncomplaint nof nclients nwith nmyasthenia ngravis, nbut nweakness nof nspecific nmuscles, nespecially nafter nprolonged nuse, nis na ncommon nsymptom. Dobutamine n(Dobutrex) nis nan nemergency ndrug nmost ncommonly nprescribed nfor na nclient nwith nwhich ncondition? A) nShock. n B) nAsthma. n C) nHypotension. n D) nHeart nfailure n- n n n ncorrect nanswer.D. Dobutamine nis na nbeta-1 nadrenergic nagonist nthat nis nindicated nfor nshort nterm nuse nin ncardiac ndecompensation nor nheart nfailure n(D) nrelated nto nreduced ncardiac ncontractility ndue nto norganic nheart ndisease nor ncardiac nsurgical nprocedures. nAlpha nand nbeta nadrenergic nagonists, nsuch nas nepinephrine nand ndopamine, nare nsympathomimetics nused nin nthe ntreatment nof nshock n(A). nOther nselective nbeta-2 nadrenergic nagonists, nsuch nas nterbutaline nand nisoproterenol, nare nindicated nin nthe ntreatment nof nasthma n(B). nAlthough ndobutamine nimproves ncardiac noutput, nit nis nnot nused nto ntreat nhypotension n(C). A nclient nwho nwas nprescribed natorvastatin n(Lipitor) none nmonth nago ncalls nthe ntriage nnurse nat nthe nclinic ncomplaining nof nmuscle npain nand nweakness nin nhis nlegs. nWhich nstatement nreflects nthe ncorrect ndrug-specific nteaching nthe nnurse nshould nprovide nto nthis nclient? A) nIncrease nconsumption nof npotassium-rich nfoods nsince nlow npotassium nlevels ncan ncause nmuscle nspasms. n B) nHave nserum nelectrolytes nchecked nat nthe nnext nscheduled nappointment nto nassess nhyponatremia, na ncause nof ncramping. n C) nMake nan nappointment nto nsee nthe nhealthcare nprovider, nbecause nmuscle npain nmay nbe nan nindication nof na nserious nside neffect. D) nBe nsure nto nconsume na nlow-cholesterol ndiet nwhile ntaking nthe ndrug nto nenhance nthe neffectiveness nof nthe ndrug. n- n n n ncorrect nanswer.C. Myopathy, nsuggested nby nthe nleg npain nand nweakness, nis na nserious, nand npotentially nlife-threatening, ncomplication nof nLipitor, nand nshould nbe nevaluated nimmediately nby nthe nhealthcare nprovider n(C). nAlthough nelectrolyte nimbalances nsuch nas n(A nor nB) ncan ncause nmuscle nspasms nin nsome ncases, nthis nis nnot nthe nlikely ncause nof nleg npain nin nthe nclient nreceiving nLipitor, nand nevaluation nby nthe nhealthcare nprovider nshould nnot nbe ndelayed nfor nany nreason. nA nlow-cholesterol ndiet nis nrecommended nfor nthose ntaking nLipitor nsince nthe ndrug nis nused nto nlower ntotal ncholesterol n(D), nbut ndiet nis nnot nrelated nto nthe nleg npain nsymptom. A npeak nand ntrough nlevel nmust nbe ndrawn nfor na nclient nreceiving nantibiotic ntherapy. nWhat nis nthe noptimum ntime nfor nthe nnurse nto nobtain nthe ntrough nlevel? A) nSixty nminutes nafter nthe nantibiotic ndose nis nadministered. n B) nImmediately nbefore nthe nnext nantibiotic ndose nis ngiven. n C) nWhen nthe nnext nblood nglucose nlevel nis nto nbe nchecked. n D) nThirty nminutes nbefore nthe nnext nantibiotic ndose nis ngiven. n- n n n ncorrect nanswer.B. Trough nlevels nare ndrawn nwhen nthe nblood nlevel nis nat nits nlowest, nwhich nis ntypically njust nbefore nthe nnext ndose nis ngiven n(B). n(A, nC, nand nD) ndo nnot ndescribe nthe noptimum ntime nfor nobtaining na ntrough nlevel nof nan nantibiotic. Which nantidiarrheal nagent nshould nbe nused nwith ncaution nin nclients ntaking nhigh ndosages nof naspirin nfor narthritis? A) nLoperamide n(Imodium). n B) nProbanthine n(Propantheline). n C) nBismuth nsubsalicylate n(Pepto nBismol). n D) nDiphenoxylate nhydrochloride nwith natropine n(Lomotil). n- n n n ncorrect nanswer.C. n Bismuth nsubsalicylate n(Pepto nBismol) ncontains na nsubsalicylate nthat nincreases nthe npotential nfor nsalicylate ntoxicity nwhen nused nconcurrently nwith naspirin n(acetylsalicylic nacid, nanother nsalicylate npreparation). n(A, nB, nand nD) ndo nnot npose nthe ndegree nof nrisk nof ndrug ninteraction nwith naspirin nas nPepto nBismol nwould. The nnurse nis nassessing nthe neffectiveness nof nhigh ndose naspirin ntherapy nfor nan n88-year-old nclient nwith narthritis. nThe nclient nreports nthat nshe ncan't nhear nthe nnurse's nquestions nbecause nher nears nare nringing. nWhat naction nshould nthe nnurse nimplement? A) nRefer nthe nclient nto nan naudiologist nfor nevaluation nof nher nhearing. n B) nAdvise nthe nclient nthat nthis nis na ncommon nside neffect nof naspirin ntherapy. n C) nNotify nthe nhealthcare nprovider nof nthis nfinding nimmediately. n D) nAsk nthe nclient nto nturn noff nher nhearing naid nduring nthe nexam. n- n n n ncorrect nanswer.C. n Tinnitus nis nan nearly nsign nof nsalicylate ntoxicity. nThe nhealthcare nprovider nshould nbe nnotified nimmediately n(C), nand nthe nmedication ndiscontinued. n(A nand nD) nare nnot nneeded, nand n(B) nis ninaccurate. The nnurse nis nassessing na nclient nwho nis nexperiencing nanaphylaxis nfrom nan ninsect nsting. nWhich nprescription nshould nthe nnurse nprepare nto nadminister nto nthis nclient A. nDopamine B. nEphedrine C. nEpinephrine D. nDiphenhydramine n- n n n ncorrect nanswer.C. n Epinephrine n(C) nis nan nadrenergic nagent nthat nstimulate nbeta nreceptors nto nincrease ncardiac nautomaticity nin ncardiac narrest nand nrelax nbronchospasms nin nanaphylaxis. nDopamine n(A) nis na nvasopressor nused nto ntreat nclients nwith nshock. nEphedrine n(B) ncauses nperipheral nvasoconstriction nand nis nused nin nthe ntreatment nof nnasal ncongestion. nDiphenhydramine n(D) nis nan nantihistamine ndecongestant nused nin nthe ntreatment nof nmild nallergic nreactions nand nmotion nsickness. The nhealthcare nprovider nprescribes nnaproxen n(Naproxen) ntwice ndaily nfor na nclient nwith nosteoarthritis nof nthe nhands. nThe nclient ntells nthe nnurse nthat nthe ndrug ndoes nnot nseem nto nbe neffective nafter nthree nweeks. nWhich nis nthe nbest nresponse nfor nthe nnurse nto nprovide? A) nThe nfrequency nof nthe ndosing nis nnecessary nto nincrease nthe neffectiveness. n B) nTherapeutic nblood nlevels nof nthis ndrug nare nreached nin n4 nto n6 nweeks. n C) nAnother ntype nof nnonsteroidal nantiinflammatory ndrug nmay nbe nindicated. n D) nSystemic ncorticosteroids nare nthe nnext ndrugs nof nchoice nfor npain nrelief. n- n n n ncorrect nanswer.C. Individual nresponses nto nnonsteroidal nantiinflammatory ndrugs nare nvariable, nso n(C) nis nthe nbest nresponse. nNaproxen nis nusually nprescribed nevery n8 nhours, nso n(A) nis nnot nindicated. nThe npeak nfor nnaproxen nis none nto ntwo nhours, nnot n(B). nCorticosteroids nare nnot nindicated nfor nosteoarthritis n(D). A ncategory nX ndrug nis nprescribed nfor na nyoung nadult nfemale nclient. nWhich ninstruction nis nmost nimportant nfor nthe nnurse nto nteach nthis nclient? A) nUse na nreliable nform nof nbirth ncontrol. n B) nAvoid nexposure nto nultra nviolet nlight. n C) nRefuse nthis nmedication nif nplanning npregnancy. n D) nAbstain nfrom nintercourse nwhile non nthis ndrug. n- n n n ncorrect nanswer.A. n Drugs nclassified nin nthe ncategory nX nplace na nclient nwho nis nin nthe nfirst ntrimester nof npregnancy nat nrisk nfor nteratogenesis, nso nwomen nin nthe nchildbearing nyears nshould nbe ncounseled nto nuse na nreliable nform nof nbirth ncontrol n(A) nduring ndrug ntherapy. n(B) nis nnot na nspecific nprecaution nwith nCategory nX ndrugs. nThe nclient nshould nbe nencouraged nto ndiscuss nplans nfor npregnancy nwith nthe nhealthcare nprovider, nso na nsafer nalternative nprescription n(C) ncan nbe nprovided nif npregnancy noccurs. nAlthough nthe nrisk nof nbirth ndefects nduring npregnancy nexplains nthe nrestriction nof nthese ndrugs nduring npregnancy, n(D) nis nnot nindicated. An nadult nclient nis ngiven na nprescription nfor na nscopolamine npatch n(Transderm nScop) nto nprevent nmotion nsickness nwhile non na ncruise. nWhich ninformation nshould nthe nnurse nprovide nto nthe nclient? A) nApply nthe npatch nat nleast n4 nhours nprior nto ndeparture. n B) nChange nthe npatch nevery nother nday nwhile non nthe ncruise. n C) nPlace nthe npatch non na nhairless narea nat nthe nbase nof nthe nskull. D) nDrink nno nmore nthan n2 nalcoholic ndrinks nduring nthe ncruise. n- n n n ncorrect nanswer.A. Scopolamine, nan nanticholinergic nagent, nis nused nto nprevent nmotion nsickness nand nhas na npeak nonset nin n6 nhours, nso nthe nclient nshould nbe ninstructed nto napply nthe npatch nat nleast n4 nhours nbefore ndeparture n(A) non nthe ncruise nship. nThe nduration nof nthe ntransdermal npatch nis n72 nhours, nso n(B) nis nnot nneeded. nScolopamine nblocks nmuscarinic nreceptors nin nthe ninner near nand nto nthe nvomiting ncenter, nso nthe nbest napplication nsite nof nthe npatch nis nbehind nthe near, nnot nat nthe nbase nof nthe nskull n(C). nAnticholinergic nmedications nare nCNS ndepressants, nso nthe nclient nshould nbe ninstructed nto navoid nalcohol n(D) nwhile nusing nthe npatch. A nclient nis nreceiving nmethylprednisolone n(Solu-Medrol) n40 nmg nIV ndaily. nThe nnurse nanticipates nan nincrease nin nwhich nlaboratory nvalue nas nthe nresult nof nthis nmedication? A) nSerum nglucose. n B) nSerum ncalcium. n C) nRed nblood ncells. n D) nSerum npotassium. n- n n n ncorrect nanswer.A. Solu-Medrol nis na ncorticosteroid nwith nglucocorticoid nand nmineralocorticoid nactions. nThese neffects ncan nlead nto nhyperglycemia n(A), nwhich nis nreflected nas nan nincrease nin nthe